HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roman Hovorka Selected Research

Critical Illness (Critically Ill)

1/2018Improving glycemic control in critically ill patients: personalized care to mimic the endocrine pancreas.
7/2014Glucose control in intensive care: usability, efficacy and safety of Space GlucoseControl in two medical European intensive care units.
6/2014Continuous glucose control in the ICU: report of a 2013 round table meeting.
2/2014Accuracy of subcutaneous continuous glucose monitoring in critically ill adults: improved sensor performance with enhanced calibrations.
7/2013Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial.
6/2013Clinical review: Consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults.
8/2012Efficacy and safety of glucose control with Space GlucoseControl in the medical intensive care unit--an open clinical investigation.
7/2011Evaluating glycemic control algorithms by computer simulations.
7/2011A stepwise approach toward closed-loop blood glucose control for intensive care unit patients: results from a feasibility study in type 1 diabetic subjects using vascular microdialysis with infrared spectrometry and a model predictive control algorithm.
5/2010Hospital glucose control: safe and reliable glycemic control using enhanced model predictive control algorithm in medical intensive care unit patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roman Hovorka Research Topics

Disease

117Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2024 - 06/2004
41Hypoglycemia (Reactive Hypoglycemia)
04/2024 - 08/2007
23Type 2 Diabetes Mellitus (MODY)
05/2024 - 01/2002
17Critical Illness (Critically Ill)
01/2018 - 02/2006
11Insulin Resistance
01/2021 - 01/2002
9Hyperglycemia
04/2024 - 05/2009
4Body Weight (Weight, Body)
12/2020 - 11/2003
2Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
03/2024 - 10/2023
1Sleepiness
09/2022
1Pulmonary Embolism
01/2022
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
01/2022
1COVID-19
01/2022
1Heart Arrest (Cardiac Arrest)
01/2022
1Diabetes Mellitus
07/2020
1Non-alcoholic Fatty Liver Disease
11/2017
1Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2013
1Hypertriglyceridemia
12/2013
1Wounds and Injuries (Trauma)
07/2013
1Cardiovascular Diseases (Cardiovascular Disease)
07/2012
1Diabetes Complications
06/2009

Drug/Important Bio-Agent (IBA)

120Insulin (Novolin)FDA Link
05/2024 - 01/2002
97Glucose (Dextrose)FDA LinkGeneric
02/2024 - 01/2002
11Insulin Aspart (NovoLog)FDA Link
01/2023 - 10/2013
10Blood Glucose (Blood Sugar)IBA
01/2018 - 07/2007
6Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
03/2024 - 01/2019
4C-PeptideIBA
01/2022 - 06/2009
3CarbohydratesIBA
02/2024 - 06/2009
3Insulin Lispro (Humalog)FDA Link
12/2023 - 11/2014
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2021 - 06/2009
2Hormones (Hormone)IBA
01/2021 - 06/2018
2Hemoglobins (Hemoglobin)IBA
11/2015 - 09/2009
2Triglycerides (Triacylglycerol)IBA
12/2013 - 07/2012
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2022
1Exenatide (Byetta)FDA Link
11/2020
1lixisenatideIBA
01/2019
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2019
1LipidsIBA
01/2019
1SugarsIBA
11/2017
1Lipoproteins (Lipoprotein)IBA
11/2017
1Dietary SugarsIBA
11/2017
1(L)-Isomer Glucose (L-Glucose)IBA
07/2017
1very low density lipoprotein triglycerideIBA
12/2013
1ChylomicronsIBA
12/2013
1LDL CholesterolIBA
07/2012
1Fatty Acids (Saturated Fatty Acids)IBA
07/2012
1LDL Lipoproteins (beta Lipoproteins)IBA
07/2012
1Insulin-Like PeptidesIBA
05/2010
1Insulin-Like Growth Factor I (IGF-1)IBA
05/2010
1Uric Acid (Urate)IBA
07/2006
1CholesterolIBA
07/2006
1HDL-triglycerideIBA
07/2006

Therapy/Procedure

56Therapeutics
02/2024 - 07/2009
17Glycemic Control
11/2023 - 02/2006
17Artificial Pancreas
07/2023 - 07/2009
3Injections
01/2020 - 01/2016
1Investigational Therapies (Experimental Therapy)
01/2023
1Critical Care (Surgical Intensive Care)
02/2014